NCT01889264

Brief Summary

Critically ill children have abnormal utilization of nutrients such as glucose, lipids and protein. Protein synthesis is increased mainly in the form of immune and signaling proteins, while muscle and structural protein synthesis is decreased. The metabolism of sulfur amino acids through the splanchnic area and specifically methionine and cysteine have not been investigated in critically ill septic children, despite that sulfur amino acids have important roles in thiol, antioxidant and epigenetic reactions. Methionine metabolism in sick children will be influenced by its rate of utilization through different pathways. Our study aims to investigate the metabolism of methionine and cysteine when both amino acids are given by the enteral route in critically ill septic children. The investigators are focused on the rates of transmethylation, remethylation and transsulfuration in critically ill septic children, and if the current standard nutrition maintains methionine nutritional balance and functional requirements in critically ill children fed by the enteral route.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 28, 2013

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

March 22, 2017

Status Verified

March 1, 2017

Enrollment Period

4.8 years

First QC Date

May 24, 2013

Last Update Submit

March 20, 2017

Conditions

Keywords

Methionine MetabolismEnteral NutritionPediatricPediatricsSepsisObservational Study

Outcome Measures

Primary Outcomes (1)

  • Methionine Metabolism

    Rates of transmethylation, remethylation and transsulfuration and erythrocyte GSH synthesis when nutrients are given by the enteral route in pediatric critically ill patients.

    Clinical Signs, AEs, SAEs, CO2, Tracer Infusion, Blood: (Baseline - 8 hours)

Study Arms (1)

Critically Ill Pediatric Patients

Critically ill septic pediatric patients, Age 1 month-3 years, Age 4-12 years and Age 13-19 years, males and females

Other: Observational

Interventions

Observational, Translational non-treatment study

Critically Ill Pediatric Patients

Eligibility Criteria

Age1 Month - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Septic pediatric patients: A total of 45 critically ill children age 1 month-19 years with diagnosis of sepsis, as defined by the International Sepsis Consensus Conference.

You may qualify if:

  • Children age 1 month-19 years
  • Diagnosis of severe sepsis diagnosed as clinical sepsis syndrome (requires two of the following criteria):
  • Source of infection
  • Fever or Hypothermia
  • Leukocytosis or Leucopenia
  • Poor organ perfusion (such as delayed capillary refill or decreased urine output or hypotension)
  • Bacteremic sepsis demonstrated by positive blood culture
  • Weight greater or equal to 4.0 kg
  • Need for enteral nutrition by a nasogastric/nasoduodenal tube
  • Presence of central and/or arterial venous access as per clinical indication

You may not qualify if:

  • Patients with metabolic diseases (i.e. Insulin dependent diabetes mellitus, urea cycle disorders, cystinuria, etc.)
  • Pregnancy
  • Primary liver failure
  • Primary renal failure
  • Patients unable to tolerate enteral feedings
  • Weight less than 4.0 kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples.

MeSH Terms

Conditions

SepsisCritical Illness

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Leticia Castillo, M.D.

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department Chair Peds Critical Care

Study Record Dates

First Submitted

May 24, 2013

First Posted

June 28, 2013

Study Start

December 1, 2011

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

March 22, 2017

Record last verified: 2017-03

Locations